Roy F. Waldron retired in 2018 as Senior Vice President‚ Associate General Counsel and Chief Intellectual Property Counsel at Pfizer. At Pfizer, he led a global team of Patent, Trademark and Copyright attorneys and professionals‚ and worked closely with R&D‚ business licensing & development and business units to develop and strengthen intellectual property strategies. He has been published numerous times in the field of intellectual property, and has often served as a panelist and keynote speaker. He is currently on the Board of Directors of Starton Therapeutics, a company specializing in transdermal drug delivery devices. Roy holds a JD from New York University School of Law‚ a PhD from Yale University and a BA from Dartmouth College.